Isolation of a colon tumor specific binding peptide using phage display selection

被引:72
作者
Kelly, KA
Jones, DA
机构
[1] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA
来源
NEOPLASIA | 2003年 / 5卷 / 05期
关键词
colon cancer; phage display; peptides; HT29; cells; CaCo-2;
D O I
10.1016/S1476-5586(03)80046-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal cancer is the third most common malignancy in the United States. Improved detection sensitivity of early colorectal neoplasms would have important clinical applications. Herein, we report on using phage display to generate peptide libraries that detect colon carcinoma tissues. To accomplish this, we employed positive selection of a peptide-bearing phage library on poorly differentiated colon carcinoma cells (HT29) and combined this with negative selection of the phage library on well-differentiated colon carcinoma cells (HCT116). Analysis of the resulting library identified a nine-amino-acid, disulfide-constrained peptide, CPIEDRPMC (RPMrel), that stained HT29 colon carcinoma cells. Immunohistochemical staining using FITC-conjugated RPMrel peptide also showed binding of RPMrel to colon tumor tissues from four patients. We saw no binding of RPMrel to normal colon tissues. In addition, RPMrel failed to stain a panel of noncolon tissues including the lungs, liver, and stomach. We further demonstrated that RPMrel coupled to the mitochondrial toxin (KLAKLAK)(2) killed HT29 cells. These studies suggest that RPMrel may be a promising lead candidate in the development of a useful colon tumor diagnostic and targeted drug delivery agent.
引用
收藏
页码:437 / 444
页数:8
相关论文
共 19 条
[1]   Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].
Arap, W ;
Pasqualini, R ;
Ruoslahti, E .
SCIENCE, 1998, 279 (5349) :377-380
[2]   HETEROGENEITY OF HUMAN-COLON CARCINOMA [J].
BRATTAIN, MG ;
LEVINE, AE ;
CHAKRABARTY, S ;
YEOMAN, LC ;
WILLSON, JKV ;
LONG, B .
CANCER AND METASTASIS REVIEWS, 1984, 3 (03) :177-191
[3]   Anti-cancer activity of targeted pro-apoptotic peptides [J].
Ellerby, HM ;
Arap, W ;
Ellerby, LM ;
Kain, R ;
Andrusiak, R ;
Del Rio, G ;
Krajewski, S ;
Lombardo, CR ;
Rao, R ;
Ruoslahti, E ;
Bredesen, DE ;
Pasqualini, R .
NATURE MEDICINE, 1999, 5 (09) :1032-1038
[4]   TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[5]   WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT [J].
FOLKMAN, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01) :4-6
[6]  
FOLLI S, 1994, CANCER RES, V54, P2643
[7]   Receptor imaging: Competitive or complementary to antibody imaging? [J].
Goldsmith, SJ .
SEMINARS IN NUCLEAR MEDICINE, 1997, 27 (02) :85-93
[8]  
Hong FD, 2000, CANCER RES, V60, P6551
[9]   PHAGE LIBRARIES DISPLAYING CYCLIC-PEPTIDES WITH DIFFERENT RING SIZES - LIGAND SPECIFICITIES OF THE RGD-DIRECTED INTEGRINS [J].
KOIVUNEN, E ;
WANG, BC ;
RUOSLAHTI, E .
BIO-TECHNOLOGY, 1995, 13 (03) :265-270
[10]   Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform [J].
Neri, D ;
Carnemolla, B ;
Nissim, A ;
Leprini, A ;
Querzè, G ;
Balza, E ;
Pini, A ;
Tarli, L ;
Halin, C ;
Neri, P ;
Zardi, L ;
Winter, G .
NATURE BIOTECHNOLOGY, 1997, 15 (12) :1271-1275